Position in PBYI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$236,730
+$67,025 QoQ
Shares Held
29,190
+9.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 42 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $896,134,901 across 107 Biotechnology names. PBYI ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in PBYI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,730 | 29,190 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $169,705 | 26,558 | Shares | Sole | 2026-05-04 | |
| 2021-09-30 | $947,934 | 135,226 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,223,510 | 133,280 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,241,846 | 127,762 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $218,927 | 21,338 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $211,668 | 20,978 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $216,537 | 20,761 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $186,161 | 22,057 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||